Does Molina Healthcare Cover Ozempic?
The verdict
Conditional on most plans
Molina Healthcare covers Ozempic for type 2 diabetes with prior authorization across its Medicaid managed-care plans, at nominal Medicaid cost-share ($0–$4 typical). Ozempic is explicitly excluded for off-label weight-loss use across all Molina lines of business. This is the structural inverse of Molina's Wegovy coverage: Medicaid covers Ozempic for T2D broadly while excluding GLP-1s for obesity in most states.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Molina Healthcare using your member ID.
Key facts
Ozempic is FDA-approved for type 2 diabetes glycemic control, cardiovascular risk reduction in T2D patients with known CVD, and CKD progression in T2D patients — not for weight loss.
FDA drug labeling (semaglutide injection)
All 50 state Medicaid programs cover GLP-1s including Ozempic for type 2 diabetes; most state Medicaid programs do not cover GLP-1s for obesity treatment.
KFF, Medicaid Coverage of and Spending on GLP-1s, 2026
The IRA Maximum Fair Price for semaglutide under Medicare is $274 per 30-day supply, effective January 1, 2027 — a 71% discount off the CY2024 list price of ~$959.
CMS, IRA Drug Price Negotiation Program, 2024
Medicare vs. commercial coverage
Whether Molina Healthcare covers Ozempic depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Advantage/Part D: Molina operates Medicare Advantage-PD plans in some states. Ozempic is covered for type 2 diabetes with prior authorization under standard Part D rules. The 2026 Part D out-of-pocket cap is $2,100. Medicare beneficiaries cannot use the NovoCare savings card — federal anti-kickback rules exclude Medicare and Medicaid enrollees. Ozempic is not covered for off-label weight-loss use under Medicare Part D. The IRA Maximum Fair Price for semaglutide is $274 per 30-day supply, effective January 1, 2027. Verify on your specific Molina Medicare Advantage plan formulary.
Commercial / Employer
Group & marketplace plans
Medicaid (primary line of business): Molina is one of the largest Medicaid MCO operators in the US. Ozempic is covered for type 2 diabetes across Molina Medicaid MCO states with prior authorization, metformin step therapy, and nominal Medicaid cost-share ($0–$4 typical per state PDL). Ozempic is explicitly not covered for off-label weight-loss use on any Molina Medicaid PDL — this mirrors the universal national Medicaid exclusion for off-label weight loss. PDL tiers and PA criteria vary by state; verify on your state-specific Molina Medicaid formulary. Commercial/Employer and ACA/Individual: Molina's commercial and ACA presence is limited. Where offered, Ozempic is covered for T2D with PA; not covered for weight loss. NovoCare savings card is not available to Medicaid or Medicare beneficiaries.
The 3 boxes you must tick to get approved
Commercial plans that will consider Ozempic require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Ozempic actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
~$1,028/month (Novo Nordisk published pricing, ~$1,027.51 for the 0.25/0.5 mg pen). NovoCare self-pay: ~$199/month intro price (first two fills through December 31, 2026), then ~$349/month (0.25/0.5/1 mg) or ~$499/month (2 mg).
List price with no coverage — before any manufacturer savings card.
With coverage
Medicaid: $0–$4 nominal cost-share for covered T2D use per state PDL — Molina's predominant line of business. Medicare Advantage/Part D (where applicable): cost-share depends on tier and plan design; $2,100 OOP cap 2026. IRA Maximum Fair Price of $274/30-day for semaglutide effective January 1, 2027 for Medicare patients. Commercial/ACA (limited): plan-specific; verify on Molina plan drug list.
Typical monthly copay once prior authorization is approved.
Bridge program
NovoCare Ozempic Savings Card: not available to Medicaid or Medicare beneficiaries (federal government program exclusion). Commercially insured T2D patients on a Molina commercial plan may be eligible ($25/fill, max $150/28-day) — verify at NovoCare.com. Most Molina enrollees are Medicaid and cannot use this card.
Reduced copay through the assistance program, where eligible.
All figures are estimates. Medicaid cost-share and tier vary by state PDL. Confirm exact cost-share with Molina member services or your state-specific Molina Medicaid plan formulary.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Find your state-specific Molina Medicaid formulary
Visit Molina Healthcare's website (molinahealthcare.com) and select your state to access the Medicaid plan drug list or preferred drug list. Ozempic coverage criteria, tier placement, and PA requirements are set at the state PDL level and can differ meaningfully between Michigan, California, Ohio, Texas, and other Molina Medicaid states. Your state's PDL is the authoritative source.
- 2
Have your prescriber submit prior authorization for T2D
Your prescriber submits the PA through Molina. Documentation typically requires: a documented T2D diagnosis (ICD-10 E11.x), evidence of a metformin trial or documented intolerance/contraindication, and the clinical indication (T2D glycemic control — not weight management). State-specific additional criteria may apply; your prescriber should verify on the Molina PA portal for your state.
- 3
Confirm cost-share and savings card eligibility
Medicaid enrollees typically pay $0–$4 nominal cost-share for Ozempic when PA is approved. The NovoCare savings card is not available to Medicaid beneficiaries. If you have Molina Medicare Advantage, the $2,100 Part D OOP cap limits 2026 exposure and the IRA price drop to $274/30-day arrives January 1, 2027. Contact Molina member services at the number on your ID card for a specific cost estimate.
Options if Molina Healthcare won't cover Ozempic
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Rybelsus (oral semaglutide)
Oral semaglutide for type 2 diabetes. Coverage and tier under Molina Medicaid vary by state PDL — verify on your state-specific Molina formulary. IRA Maximum Fair Price of $274/30-day takes effect January 1, 2027 for Medicare patients.
Jardiance (empagliflozin)
SGLT-2 inhibitor commonly used as oral step-therapy before GLP-1 approval. Often a preferred brand tier on state Medicaid PDLs with lower cost-share than Ozempic.
Metformin (generic)
Universally covered on Medicaid PDLs at $0–$1 copay. Required step therapy before Ozempic PA approval on all Molina Medicaid state plans.
Compounded semaglutide (weight-loss seekers only)
For patients seeking semaglutide for weight management — not T2D — who are denied under Molina Medicaid (which explicitly excludes GLP-1s for obesity in most states), compounded semaglutide from $49/mo is available at getcurex.com/cl/glp without insurance. See the offer section below for full disclaimers.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. Molina Healthcare explicitly excludes Ozempic for off-label weight-loss use across all Medicaid, commercial, and Medicare lines of business. Ozempic is FDA-approved only for type 2 diabetes — not for weight management. Molina Medicaid in most states also excludes GLP-1s for obesity treatment (with limited exceptions for on-label Wegovy where applicable). If you are searching for coverage for weight loss, Molina will not cover Ozempic for that indication.
Yes. Molina Medicaid covers Ozempic for type 2 diabetes with prior authorization at nominal Medicaid cost-share ($0–$4 typical) per state preferred drug list. PA requires a T2D diagnosis and documented metformin step therapy. Coverage details vary by state — Molina operates Medicaid MCOs in California, Texas, Ohio, Michigan, Washington, and other states, each with its own PDL. Verify on your state-specific Molina Medicaid formulary or call member services.
No, if you are enrolled in Molina Medicaid or Medicare Advantage. Federal anti-kickback rules prohibit Medicaid and Medicare beneficiaries from using manufacturer savings cards, including the NovoCare Ozempic Savings Card. Because Molina's predominant enrollment is in Medicaid managed care, most Molina members cannot use the savings card. Commercially insured patients on a limited Molina commercial plan may be eligible — verify at NovoCare.com.
Molina's Ozempic and Wegovy coverage stories are nearly opposite. Ozempic for type 2 diabetes is covered at $0–$4 Medicaid copay across Molina states. Wegovy for obesity is explicitly excluded under most Molina Medicaid PDLs — with limited exceptions in select states. This T2D/obesity split shows how the same insurer can cover one GLP-1 for one indication while excluding another. Always verify the specific drug and indication on your state's Molina PDL.
Molina Medicaid plans near-universally require documented metformin use as the first step — or documented medical intolerance or contraindication to metformin — before approving Ozempic for T2D. Some state Medicaid PDLs require A1c documentation or an additional oral agent trial; specific thresholds are not consistently confirmed in primary state PDL documents and vary by state. Ask your prescriber to review your state's specific Molina Medicaid PA criteria before submitting to avoid delays.
Related Articles
Does Molina Healthcare Cover Vyvanse? 2026
Molina covers Vyvanse for ADHD and binge-eating disorder with PA — generic preferred, brand non-preferred. One stimulant at a time rule; 70 mg/day QL.
Read moreDoes Molina Healthcare Cover Wegovy? 2026 State Guide | Curex
Molina covers Wegovy for obesity only in the 13 states with Medicaid GLP-1 coverage as of 2026. Most Molina states exclude it. Check your state PDL.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Molina Healthcare Cover Mounjaro? 2026 | Curex
Molina Healthcare covers Mounjaro for T2D at $0-$4 Medicaid copay with prior auth — not weight loss. GLP-1s for obesity are excluded in most Molina states.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreDoes Molina Healthcare Cover Adderall? 2026 | Curex
Molina covers Adderall on Medicaid and Marketplace plans — one stimulant at a time PA rule, generic preferred. Brand non-preferred. State PDL rules vary.
Read moreInsurance won't cover Ozempic for weight loss — here's a path that doesn't need it
Molina Medicaid explicitly excludes GLP-1s for obesity treatment in most states — and no insurer covers Ozempic for weight loss. Patients seeking semaglutide for weight management without a diabetes diagnosis will be denied. Curex offers compounded semaglutide starting at $49/mo with no insurance required and no prior authorization. Compounded semaglutide is not the same medication as Ozempic or Wegovy. Compounded tirzepatide is also available from $149/mo. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Ozempic and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Molina Healthcare before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Ozempic and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.